SOURCE: Pyng Medical Corp.

August 02, 2005 09:00 ET

Pyng Medical Corp. Recertifies Its World Class Quality Management Systems

RICHMOND, BC -- (MARKET WIRE) -- August 2, 2005 -- Pyng Medical Corp. (TSX-V: PYT) (OTC BB: PYNGF) is pleased to announce the continuing recertification of its world class Quality Management Systems. A recent surveillance audit by S.G.S International, Pyng Medical Corp. accredited third party registrar and notified body was performed to ISO 9001:2000, ISO 13485:2003, Canadian Medical Device Regulations, and Medical Directive 93/42/EEC Annex II (excluding section 4) for CE Marking. The company is already in full compliance to FDA's Quality System Requirements.

The registration audit and the surveillance audit in both instances had No Major Non Conformances and also No Minor Non Conformances.

This accomplishment is very significant in that Pyng Medical Corp. has now accomplished back to back audits with no non-conformances. This is testament to Pyng Medical Corp. adherence to producing high quality product to all International standards under Pyng Medical Corp. quality control management.

Pyng Medical Corp. has had significant changes, including organizational restructuring, incredible growth, increased production, and supplier changes, all of which tested the robustness of Pyng's Quality Systems. The S.G.S. International audit confirms the standards by which Pyng Medical Corp. is delivering its products.

We also recognize the importance of our quality system, in house production capacity such as our class 10,000 clean room and engineering capabilities, as all being key and integral components of our strategic plan to broaden our product line.

For further information please contact Pyng Medical Corp. at 1-604-303-7964 or visit our Web site at

Michael W. Jacobs, Chairman, Pyng Medical Corp.

The Toronto Venture Exchange has neither reviewed nor approved of the contents of this News Release. Safe Harbor Statement: This release may contain certain forward-looking statements including without limitation, projections, assumptions, expectations, product development objectives, commercial introduction, and potential advantages of the F.A.S.T.1™ System. Actual events or results may differ from the Company's expectations as a result of risk factors discussed in Pyng Medical Corp. reports on file with the U.S. Securities and Exchange Commission.

Contact Information